Nursing Home Influenza Vaccine Study
A team of nationally recognized long-term care researchers from Case Western Reserve University and Brown University, Stefan Gravenstein, MD, MPH, CMD, and Vincent Mor, PhD, are recruiting for a national quality improvement study. The study will evaluate the impact of the annual influenza vaccine choice on long-term care facility residents' hospitalization risk for the 2016-2017 influenza season. Eligible nursing facilities that agree to participate will be allocated to either the standard annual trivalent influenza vaccine or the adjuvanted trivalent influenza vaccine, Fluad. Both of these vaccines are recommended by the CDC for annual protection against influenza infection in adults. Facilities will receive a free supply of vaccine for the 2016-17 annual vaccination, compensation for data entry, and free supply of vaccine for facility staff.
If you are interested in participating in this study, please notify the researchers by calling their study coordinating center, Insight Therapeutics, LLC, at 757-625-6040, or via email to H. Edward Davidson, PharmD, MPH, at NHFluStudy@inther.com. They can provide you with a description of the study objectives and procedures.
This is an informational email only. The Department of Health Services does not promote or endorse participation in the above study.
|
